Genmab is an English word starting with the letter G. With 10+ example sentences you'll see exactly how it works in context.
Genmab in a sentence
Using Genmab
- In the example corpus, genmab often appears in combinations such as: of genmab, genmab from, that genmab.
Context around Genmab
- Average sentence length in these examples: 19.7 words
- Position in the sentence: 4 start, 6 middle, 0 end
- Sentence types: 10 statements, 0 questions, 0 exclamations
Corpus analysis for Genmab
- In this selection, "genmab" usually appears in the middle of the sentence. The average example has 19.7 words, and this corpus slice is mostly made up of statements.
- Around the word, raised and may stand out and add context to how "genmab" is used.
- Recognizable usage signals include 1 of genmab a s and acquired by genmab for 1. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "genmab" sits close to words such as aadi, aayush and abbottabad, which helps place it inside the broader word index.
Example types with genmab
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Two analysts have issued estimates for Genmab A/S’s earnings. (11 words)
Comparatively, 7.1% of Genmab A/S shares are owned by institutional investors. (13 words)
ProfoundBio announced last week that it will be acquired by Genmab for $1.8 billion. (15 words)
Please also note that Genmab may hold your personal data as indicated by you as part of our Investor Relations outreach activities in order to update you on Genmab going. (30 words)
H.C. has a Buy rating and a $25 per share price target on Genmab, whose stock is trading today at around $23.04 per share. (26 words)
UBS Group raised shares of Genmab A/S from a “neutral” rating to a “buy” rating in a research report on Wednesday, December 6th. (24 words)
Example sentences (10)
Please also note that Genmab may hold your personal data as indicated by you as part of our Investor Relations outreach activities in order to update you on Genmab going.
Finally, Danske raised Genmab A/S from a hold rating to a buy rating in a report on Thursday, February 23rd.
Finally, Harding Loevner LP lifted its position in Genmab A/S by 38.4% in the 1st quarter.
Comparatively, 7.1% of Genmab A/S shares are owned by institutional investors.
Equities research analysts forecast that Genmab A/S will post 1.19 EPS for the current year.
ProfoundBio announced last week that it will be acquired by Genmab for $1.8 billion.
UBS Group raised shares of Genmab A/S from a “neutral” rating to a “buy” rating in a research report on Wednesday, December 6th.
H.C. has a Buy rating and a $25 per share price target on Genmab, whose stock is trading today at around $23.04 per share.
Bank of America raised Genmab A/S from a “neutral” rating to a “buy” rating in a report on Friday, September 13th.
Two analysts have issued estimates for Genmab A/S’s earnings.
Common combinations with genmab
These word pairs occur most frequently in English texts:
- of genmab 3×
- genmab from 3×
- that genmab 2×
- on genmab 2×
- raised genmab 2×